Snippets | GenomeWeb

Snippets

Premium
Transgenomic to Buy Rights to Power3's Neurodegenerative Disease Tests
 
Transgenomic said this week that it has signed a letter of intent to buy the rights to Power3 Medical Products’ neurodegenerative biomarkers, including NuroPro, a blood serum-based diagnostic for Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease.
 
Transgenomic plans to offer NuroPro through its CLIA-certified molecular diagnostics lab.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.